Barclays Analysts Give Medical Properties Trust (NYSE:MPW) a $22.00 Price Target

Barclays set a $22.00 price target on Medical Properties Trust (NYSE:MPW) in a report published on Monday, TipRanks reports. The firm currently has a buy rating on the real estate investment trust’s stock.

A number of other analysts also recently commented on the stock. Zacks Investment Research upgraded shares of Medical Properties Trust from a hold rating to a buy rating and set a $22.00 price target on the stock in a research report on Wednesday, October 16th. Deutsche Bank raised shares of Medical Properties Trust from a hold rating to a buy rating in a research note on Monday, July 29th. Berenberg Bank assumed coverage on shares of Medical Properties Trust in a research note on Thursday, September 12th. They issued a buy rating and a $22.00 price objective on the stock. ValuEngine cut shares of Medical Properties Trust from a buy rating to a hold rating in a research note on Thursday, August 1st. Finally, JPMorgan Chase & Co. set a $21.00 price objective on shares of Medical Properties Trust and gave the stock a buy rating in a research note on Wednesday, September 4th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of Buy and an average price target of $20.18.

MPW stock opened at $20.54 on Monday. Medical Properties Trust has a 52 week low of $14.62 and a 52 week high of $20.59. The company has a market capitalization of $9.03 billion, a price-to-earnings ratio of 14.99, a price-to-earnings-growth ratio of 4.11 and a beta of 0.53. The firm’s 50-day moving average is $19.41 and its two-hundred day moving average is $18.37. The company has a current ratio of 8.00, a quick ratio of 8.00 and a debt-to-equity ratio of 0.99.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 EPS for the quarter, hitting analysts’ consensus estimates of $0.31. Medical Properties Trust had a net margin of 129.20% and a return on equity of 6.84%. The company had revenue of $192.55 million for the quarter, compared to the consensus estimate of $186.11 million. During the same period in the previous year, the firm earned $0.36 EPS. Medical Properties Trust’s revenue was down 4.6% on a year-over-year basis. On average, equities research analysts predict that Medical Properties Trust will post 1.31 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 10th. Stockholders of record on Thursday, September 12th were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, September 11th. This represents a $1.04 annualized dividend and a dividend yield of 5.06%. This is a boost from Medical Properties Trust’s previous quarterly dividend of $0.25. Medical Properties Trust’s payout ratio is currently 75.91%.

In other news, insider Emmett E. Mclean sold 100,000 shares of Medical Properties Trust stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $18.37, for a total value of $1,837,000.00. Following the transaction, the insider now owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Edward K. Aldag, Jr. sold 101,964 shares of Medical Properties Trust stock in a transaction that occurred on Thursday, October 10th. The stock was sold at an average price of $19.78, for a total transaction of $2,016,847.92. Following the completion of the transaction, the chief executive officer now directly owns 2,058,820 shares in the company, valued at $40,723,459.60. The disclosure for this sale can be found here. Insiders sold a total of 349,464 shares of company stock worth $6,603,573 in the last ninety days. Corporate insiders own 1.18% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Medical Properties Trust by 4.4% in the second quarter. Vanguard Group Inc. now owns 59,568,283 shares of the real estate investment trust’s stock worth $1,038,870,000 after acquiring an additional 2,531,875 shares in the last quarter. BlackRock Inc. increased its position in shares of Medical Properties Trust by 1.6% in the second quarter. BlackRock Inc. now owns 45,070,249 shares of the real estate investment trust’s stock worth $786,026,000 after acquiring an additional 702,061 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Medical Properties Trust by 6.3% in the second quarter. Bank of New York Mellon Corp now owns 11,407,543 shares of the real estate investment trust’s stock worth $198,948,000 after acquiring an additional 676,813 shares in the last quarter. Bank of America Corp DE increased its position in shares of Medical Properties Trust by 33.1% in the second quarter. Bank of America Corp DE now owns 5,779,755 shares of the real estate investment trust’s stock worth $100,799,000 after acquiring an additional 1,438,268 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Medical Properties Trust by 2.2% in the second quarter. Northern Trust Corp now owns 5,308,036 shares of the real estate investment trust’s stock worth $92,572,000 after acquiring an additional 115,719 shares in the last quarter. 71.35% of the stock is currently owned by institutional investors and hedge funds.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Featured Story: The Role of a Fiduciary and Individual Investors

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.